Use of dynamic contrast-enhanced MRI to measure subtle blood-brain barrier abnormalities

Magnetic Resonance Imaging

Volumn 29, Issue 3, 2011, Pages 305-314

  Armitage, Paul A ^a   Farrall, Andrew J ^a   Carpenter, Trevor K ^a   Doubal, Fergus N ^a   Wardlaw, Joanna M ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Blood brain barrier; MRI; Permeability; Stroke

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE;

AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN TISSUE; CEREBROVASCULAR ACCIDENT; CONCENTRATION RESPONSE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; EFFECT SIZE; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELIABILITY; SIGNAL NOISE RATIO; WHITE MATTER;

AGED; BLOOD-BRAIN BARRIER; CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 79952533267     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2010.09.002     Document Type: Article

References (37)

1. Brix G., Semmler W., Port R., Schad L.R., Layer G., Lorenz W.J. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991, 15:621-628.
2. Parker G.J.M., Tofts P.S. Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging. Top Magn Reson Imag 1999, 10:130-142.
3. Harrer J.U., Parker G.J.M., Haroon H.A., Buckley D.L., Embelton K., Roberts C., Baleriaux D., Jackson A. Comparative study of methods for determining vascular permeability and blood volume in human gliomas. J Magn Reson Imaging 2004, 20:748-757.
4. Kermode A.G., Thompson A.J., Tofts P.S. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: pathogenic and clinical implications. Brain 1990, 113:1477-1489.
5. Katz D., Taubenberger J.K., Hashimoto S.A. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993, 34:661-669.
6. Tofts P.S., Kermode A.G. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging: 1. Fundamental concepts. Magn Reson Med 1991, 17:357-367.
7. Farrall A.J., Wardlaw J.M. Blood-brain barrier: ageing and microvascular disease - systematic review and meta analysis. Neurobiol Aging 2007, 13.
8. Berger J.R., Nath A., Greenberg R.N., Andersen A.H., Greene R.A., Bognar A., Avison M.J. Cerebrovascular changes in the basal ganglia with HIV dementia. Neurology 2000, 54:921-926.
9. Avison M.J., Nath A., Greene-Avison R., Schmitt F.A., Greenberg R.N., Berger J.R. Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol 2004, 157:140-146.
10. Bronge L., Wahlund L.O. White matter lesions in dementia: an MRI study on blood-brain barrier dysfunction. Dement Geriatr Cogn Disord 2000, 11:263-267.
11. Wahlund L.O., Bronge L. Contrast-enhanced MRI of white matter lesions in patients with blood-brain barrier dysfunction. Ann NY Acad Sci 2000, 903:477-481.
12. Hanyu H., Asano T., Tanaka Y., Iwamoto T., Takasaki M., Abe K. Increased blood-brain barrier permeability in white matter lesions of Binswanger's disease evaluated by contrast-enhanced MRI. Dement Geriatr Cogn Disord 2002, 14:1-6.
13. Starr J.M., Farrall A.J., Armitage P., McGunn B., Wardlaw J. Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study. Psychiatry Research 2009, 171(3):232-241.
14. Starr J.M., Wardlaw J., Ferguson K., MacLullich A., Deary I.J., Marshall I. Increased blood-brain barrier permeability in type II diabetes demonstrated by gadolinium magnetic resonance imaging. J Neurol Neurosurg Psychiatry 2003, 74:70-76.
15. Wardlaw J.M., Farrall A., Armitage P.A., Carpenter T., Chappell F Doubal F., Chowdhury D., Cvoro V., Dennis M.S. Changes in background blood-brain barrier integrity between lacunar and cortical ischemic stroke subtypes. Stroke 2008, 39(4):1327-1332.
16. Soon D., Tozer D.J., Altmann D.R., Tofts P.S., Miller D.H. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes. Mult Scler 2007, 13:884-894.
17. Soon D., Altmann D.R., Fernando K.T.M., Giovannoni G., Barkhof F., Polman C.H., O'Connor P., Gray B., Panzara M., Miller D.H. A study of subtle blood-brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis. J Neurol 2007, 254:306-314.
18. Andersen C., Jensen F.T. Differences in blood-tumour-barrier leakage of human intracranial tumours: quantitative monitoring of vasogenic oedema and its response to glucocorticoid treatment. Acta Neurochir 1998, 140:919-924.
19. Schabel M.C., Parker D.L. Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences. Phys Med Biol 2008, 53:2345-2373.
20. Tofts P.S., Berkowitz B., Schnall M.D. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995, 33:564-568.
21. Wang H.Z., Riederer S.J., Lee J.N. Optimizing the precision in T1 relaxation estimation using limited flip angles. Magn Reson Med 1987, 5:399-416.
22. Brookes J.A., Redpath T.W., Gilbert F.J., Murray A.D., Staff R.T. Accuracy of T1 measurement in dynamic contrast-enhanced breast MRI using two- and three-dimensional variable flip angle fast low-angle shot. J. Magn Reson Imaging 1999, 9:163-171.
23. Deoni S.C.L., Rutt B.K., Peters T.M. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med 2003, 49:515-526.
24. Armitage P., Behrenbruch C., Brady M. Optimised brain T1 measurement using multiple flip angle gradient-echo acquisitions. Book of abstracts: Eleventh Annual Meeting of the International Society of Magnetic Resonance in Medicine 2003, 2443. ISMRM, Berkeley, CA.
25. Cheng H.L.M., Wright G.A. Rapid high-resolution T(1) mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity. Magn Reson Med 2006, 55:566-574.
26. Schabel M.C., Morrell G.R. Uncertainty in T1 mapping using the variable flip angle method with two flip angles. Phys Med Biol 2009, 54:N1-N8.
27. Fazekas F., Kleinert R., Offenbacher H., Schmidt R., Kleinert G., Payer F., Radner H., Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993, 43:1683-1689.
28. Jenkinson M., Smith S. A global optimization method for robust affine registration of brain images. Med Image Anal 2001, 5:143-156.
29. Armitage P., Behrenbruch C., Brady M., Moore N. Extracting and visualizing physiological parameters using dynamic contrast-enhanced magnetic resonance imaging of the breast. Med Image Anal 2005, 9:315-329.
30. Rohrer M., Bauer H., Mintorovitch J., Requardt M., Weinmann H.J. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005, 40:715-724.
31. Siemonsen S., Finsterbusch J., Matschke J., Lorenzen A., Ding X.Q., Fiehler J. Age-dependent normal values of T2* and T2' in brain parenchyma. AJNR 2008, 29:950-955.
32. Stanisz G.J., Henkelman R.M. Gd-DTPA relaxivity depends on macromolecular content. Magn Reson Med 2000, 44:665-667.
33. Pickup S., Wood A.K.W., Kundel H.L. Gadodiamide T1 relaxivity in brain tissue in vivo is lower than in saline. Magn Reson Med 2005, 53:35-40.
34. Donahue K.M., Burstein D., Manning W.J., Gray M.L. Studies of Gd-DTPA relaxivity and proton exchange rates in tissue. Magn Reson Med 1994, 32:66-76.
35. Ibrahim M.A., Emerson J.F., Cotman C.W. Magnetic resonance imaging relaxation times and gadolinium-DTPA relaxivity values in human cerebrospinal fluid. Invest Radiol 1998, 33:153-162.
36. Dimicoli J.L., Patry J., Poupon J., Volk A. On the use of R1 and R2* for measurement of contrast agent concentration in isolated perfused rat liver. NMR Biomed 2003, 16:276-285.
37. Shuter B., Tofts P.S., Wang S.C., Pope J.M. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat. Magn Reson Imag 1996, 14:243-253.